Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Immune Cell Distributions in the Blood of Healthy Individuals at High Genetic Risk of Parkinson’s Disease

Laura Deecke, David Goldeck, Olena Ohlei, Jan Homann, Ilja Demuth, Lars Bertram, Graham Pawelec, Christina M. Lill*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

The immune system likely plays a key role in Parkinson’s disease (PD) pathophysiology. Thus, we investigated whether immune cell compositions are already altered in healthy individuals at high genetic risk for PD. We quantified 92 immune cell subtypes in the blood of 442 individuals using multicolor flow cytometry. Polygenic risk scores (PGS) for PD were calculated based on genome-wide significant SNPs (n = 87) from a large genome-wide association study (n = 1,530,403). Linear regression analyses did not reveal significant associations between PGS and any immune cell subtype (FDR = 0.05). Nominally significant associations were observed for NKG2C+ B cells (p = 0.026) in the overall sample. Older participants at increased genetic PD risk also showed a higher proportion of myeloid dendritic cells (p = 0.019) and CD27+CD4+ memory T cells (p = 0.043). Several immune cells were nominally statistically associated in women only. These findings suggest that major alterations of immune cells only occur later in the progression of PD.

OriginalspracheEnglisch
Aufsatznummer13655
ZeitschriftInternational Journal of Molecular Sciences
Jahrgang25
Ausgabenummer24
ISSN1661-6596
DOIs
PublikationsstatusVeröffentlicht - 12.2024

Fördermittel

The BASE-II research project (co-PIs: Lars Bertram, Ilja Demuth, Denis Gerstorf, Ulman Lindenberger, Graham Pawelec, Elisabeth Steinhagen-Thiessen, and Gert G. Wagner) has been supported by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) under grant numbers #16SV5536K, #16SV5537, #16SV5538, #16SV5837, #01UW0808, #01GL1716A, and #01GL1716B, and by the Max Planck Institute for Human Development, Berlin, Germany. Additional contributions (e.g., equipment, logistics, personnel) were made from each of the other participating sites. The responsibility for the contents of this publication lies with its authors. C.M.L. was supported by the Heisenberg program of the German Research Foundation (DFG; LI 2654/4-1).

TrägerTrägernummer
Max-Planck-Gesellschaft
Bundesministerium für Bildung und Forschung16SV5536K, 01GL1716B, 01GL1716A, 01UW0808, 16SV5538, 16SV5537, 16SV5837
Deutsche ForschungsgemeinschaftLI 2654/4-1

    UN SDGs

    Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

    1. SDG 3 – Gesundheit und Wohlergehen
      SDG 3 – Gesundheit und Wohlergehen

    Strategische Forschungsbereiche und Zentren

    • Querschnittsbereich: Medizinische Genetik

    DFG-Fachsystematik

    • 2.23-06 Molekulare und zelluläre Neurologie und Neuropathologie

    Fingerprint

    Untersuchen Sie die Forschungsthemen von „Immune Cell Distributions in the Blood of Healthy Individuals at High Genetic Risk of Parkinson’s Disease“. Zusammen bilden sie einen einzigartigen Fingerprint.

    Zitieren